Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;58(5):539-547.
doi: 10.1007/s00592-020-01623-4. Epub 2020 Oct 31.

Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review

N A M Asarani  1 , A N Reynolds  2 , M Elbalshy  1 , M Burnside  3 , M de Bock  3 , D M Lewis  4 , B J Wheeler  5
Affiliations

Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review

N A M Asarani et al. Acta Diabetol. 2021 May.

Abstract

The do-it-yourself artificial pancreas system (DIYAPS) is a patient-driven initiative with the potential to revolutionise diabetes management, automating insulin delivery with existing pumps and CGM combined with open-source algorithms. Given the considerable interest in this topic within the diabetes community, we have conducted a systematic review of DIYAPS efficacy, safety, and user experience. Following recognised procedures and reporting standards, we identified 10 eligible publications of 730 participants within the peer-reviewed literature. Overall, studies reported improvements in time in range, HbA1c (glycated haemoglobin), reduced hypoglycaemia, and improved quality of life with DIYAPS use. While results were positive, the identified studies were small, and the majority were observational and at high risk of bias. Further research including well-designed randomised trials comparing DIYAPS with appropriate comparators is recommended.

Keywords: Artificial pancreas; Do-it-yourself; Glucose sensing technology; Open-source.

PubMed Disclaimer

References

    1. OpenAPS Outcomes [Available from: https://openaps.org/outcomes/ .
    1. FDA approves first automated insulin delivery device for type 1 diabetes (2016) [Available from: https://www.fda.gov/news-events/press-announcements/fda-approves-first-a... .
    1. Certain Medtronic MiniMed Insulin Pumps Have Potential Cybersecurity Risks: FDA Safety Communication. FDA2019 (2019) [Available from: https://www.fda.gov/medical-devices/safety-communications/certain-medtro... .
    1. Position statement: people with type 1 diabetes and do it yourself (DIY) technology solutions. Diabetes Australia2018 (2018)[Available from: https://static.diabetesaustralia.com.au/s/fileassets/diabetes-australia/... .
    1. Tandem Diabetes Care Announces FDA Clearance of the t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology (2019) [Available from: https://investor.tandemdiabetes.com/news-releases/news-release-details/t... .

Publication types

MeSH terms

LinkOut - more resources